Adicet Bio, Inc. Proceeds from Issuance of Warrants
Adicet Bio, Inc. (ACET) reported Proceeds from Issuance of Warrants of $75.17 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-12
- Adicet Bio, Inc. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $75.17M.
- Adicet Bio, Inc. proceeds from issuance of warrants for the quarter ending 2025-09-30 was $0.00.
- Adicet Bio, Inc. proceeds from issuance of warrants for the quarter ending 2025-06-30 was $0.00.
- Adicet Bio, Inc. proceeds from issuance of warrants for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Adicet Bio, Inc. proceeds from issuance of warrants for fiscal 2025 was $75.17M, a 17.98% decline from fiscal 2024.
- Adicet Bio, Inc. proceeds from issuance of warrants for fiscal 2024 was $91.65M.
- Adicet Bio, Inc. proceeds from issuance of warrants for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $75.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $75.17M derived: sum of 2 quarters · filed 2026-03-12 | $75.17M derived: sum of 3 quarters · filed 2026-03-12 | $75.17M 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $91.65M 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $91.65M 10-Q · filed 2025-11-05 | $91.65M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $91.65M 10-Q · filed 2025-08-07 | $91.65M derived: sum of 3 quarters · filed 2025-08-07 | $91.65M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $91.65M 10-Q · filed 2025-05-06 | $91.65M derived: sum of 2 quarters · filed 2025-05-06 | $91.65M derived: sum of 3 quarters · filed 2025-05-06 | $91.65M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |